Paper Details
- Home
- Paper Details
Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review.
Author: DimovaMaria, GeorgievTsvetoslav, GerganovGeorgi, ShivachevaTanya
Original Abstract of the Article :
Rheumatoid arthritis (RA) increases the risk of cardiovascular disease (CVD), with inflammation playing a key role. Biologic and targeted synthetic drugs used to treat RA can induce systemic immunomodulation and may have pleiotropic effects on vascular function, making it crucial to investigate thei...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s10067-023-06587-8
データ提供:米国国立医学図書館(NLM)
Vascular Effects of Biologic and Targeted Synthetic Anti-Rheumatic Drugs
Rheumatoid arthritis (RA) is a chronic inflammatory disease that can wreak havoc on the body, including the cardiovascular system. Biologic and targeted synthetic drugs have emerged as powerful weapons against RA, but their impact on vascular health remains a topic of much debate. This systematic review dives into the intricate relationship between these drugs and vascular function, aiming to shed light on their potential effects on cardiovascular risk in patients with RA. The researchers conducted a comprehensive search of available literature to evaluate the vascular effects of these drugs, taking a closer look at their potential benefits and risks for cardiovascular health. The review serves as a valuable guide for understanding the complex interplay between RA treatment and cardiovascular health.
The Vascular Implications of RA Treatment
This systematic review provides a comprehensive overview of the vascular effects of biologic and targeted synthetic drugs used to treat RA. The findings highlight the need for a careful consideration of potential cardiovascular risks associated with these drugs. Clinicians should monitor patients closely for any signs of cardiovascular complications and adjust treatment strategies as needed to optimize both RA control and cardiovascular health.
Navigating the Crossroads of RA and Cardiovascular Health
The intricate relationship between RA and cardiovascular disease presents a unique challenge for clinicians. This systematic review sheds light on the vascular effects of biologic and targeted synthetic drugs used to treat RA, providing valuable insights into their potential impact on cardiovascular risk. The findings emphasize the importance of individualized treatment approaches, considering both the benefits and risks of these medications in relation to each patient's specific needs and cardiovascular health profile.
Dr.Camel's Conclusion
This systematic review serves as a valuable resource for understanding the complex interplay between RA treatment and vascular health. The findings underscore the importance of ongoing research to further explore the cardiovascular effects of biologic and targeted synthetic drugs, ultimately aiming to ensure safe and effective treatment strategies for patients with RA.
Date :
- Date Completed 2023-09-13
- Date Revised 2023-09-22
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.